IMMG OTC
Immage Biotherapeutics Corp.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$9K
+0.0% ▲
Operating Income
-$216K
-368269.5% ▼
Net Income
-$216K
-368269.5% ▼
EPS (Diluted)
$-0.00
-150.0% ▼
EBITDA
-$208K
-358845.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $9K |
| Gross Profit | $0 | $0 | $0 | $0 | -$9K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $62K |
| SG&A Expenses | $8 | $12 | $19 | $59 | $146K |
| Operating Expenses | $8 | $12 | $19 | $59 | $208K |
| Operating Income | -$8 | -$12K | -$19K | -$59 | -$216K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$8 | -$12 | -$19 | -$59 | -$216K |
| Tax Expense | $0 | -$0 | -$0 | $0 | $0 |
| Net Income | -$8 | -$12K | -$19K | -$59 | -$216K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.00 | $-0.01 | $-0.03 | $-0.00 | $-0.00 |
| EBITDA | $0 | -$12K | -$19K | -$58 | -$208K |
| Shares Outstanding | 1M | 1M | 561289 | 101994 | 145M |